Drugs / INTEGRA™ Flowable Wound Matrix
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01108263 Comparator | Jun 2010 → Aug 2011 | diabetes mellitus, ulcer of lower limbs | Georgetown University | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INTEGRA Flowable Wound Matrix | “INTEGRA™ Flowable Wound Matrix is an advanced 3-D porous matrix comprised of granulated cross-linked bovine tendon collagen and glycosaminoglycan.” NCT01108263 ↗ |
| Route | Topical | “applied onto the wound” NCT01108263 ↗ |